Voyager Therapeutics VYGR
NASDAQ VYGR
$2.68 +0.04 (+1.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Revenue (2015 - 2026)

Updated

Voyager Therapeutics (VYGR) reported Revenue of $3.2 million for Q2 2026, down 38.5% from $5.2 million a year earlier but up 23.1% from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Revenue (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Voyager Therapeutics' Revenue came in at $34.54 million, down 18.9% year-over-year; for FY2025, it came in at $40.37 million, down 49.5% from FY2024.

  • Revenue has a five-year compound annual growth rate of -25.1% (FY2020 to FY2025).
  • By year, Revenue came in at $80 million in FY2024 (-68.0%), $250.01 million in FY2023 (+511.2%), $40.91 million in FY2022 (+9.3%) and $37.42 million in FY2021 (-78.1%).
  • Five-year quarterly Revenue spans a low of -$1.55 million in Q4 2022 and a high of $150.48 million in Q1 2023.
  • Year over year, Revenue gained in two of the last eight quarters, with growth averaging 24.0%.
  • The high point for year-over-year Revenue in five years was Q2 2023 (growth of 588.2%); the low point was Q3 2021 (a decline of 98.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.6 million (Q1 2026), $15.34 million (Q4 2025) and $13.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Voyager Therapeutics 161.76 Mn -501.43 Mn - 3.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.20 Mn
Mar 31, 2026 2.60 Mn
Dec 31, 2025 15.34 Mn
Sep 30, 2025 13.40 Mn
Jun 30, 2025 5.20 Mn
Mar 31, 2025 6.50 Mn
Dec 31, 2024 6.28 Mn
Sep 30, 2024 24.63 Mn
Jun 30, 2024 29.60 Mn
Mar 31, 2024 19.52 Mn
Dec 31, 2023 90.06 Mn
Sep 30, 2023 4.61 Mn
Jun 30, 2023 4.90 Mn
Mar 31, 2023 150.48 Mn
Dec 31, 2022 -1.55 Mn
Sep 30, 2022 41.09 Mn
Jun 30, 2022 712,000.00
Mar 31, 2022 658,000.00
Dec 31, 2021 28.07 Mn
Sep 30, 2021 1.48 Mn
API Access

Voyager Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=VYGR&period=max&api_key=YOUR_API_KEY